CITADEL ADVISORS LLC
Position in DMAA — Drugs Made In America Acquisition Corp.
CIK 1423053
MIAMI, FL
Position in DMAA
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$109,788
-$14,637 QoQ
Shares Held
10,476
-12.4% QoQ
Ownership
0.043%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DMAA Over Time
Shares Held
Position Value (USD)
Position in Shell Companies
Financial Services · as of Jun 30, 2026CITADEL ADVISORS LLC holds $114,000,865 across 75 Shell Companies names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CCXI |
Churchill Capital Corp XI
|
3,253,289 | $56,769,893 | |
| 2 | DYNC |
Dynamix Corp
|
1,268,869 | $13,691,096 | |
| 3 | VLOS |
Velos Acquisition I Corp.
|
753,709 | $8,162,667 | |
| 4 | JATT |
JATT II Acquisition Corp.
|
319,986 | $3,635,040 | |
| 5 | CEPF |
Cantor Equity Partners IV, Inc.
|
291,119 | $3,027,637 | |
| 6 | AMAN |
Amanat Acquisition Corp.
|
284,637 | $2,891,911 | |
| 7 | ATII |
Archimedes Tech SPAC Partners II Co.
|
250,266 | $2,697,867 | |
| 8 | CAES |
Cantor Equity Partners VII, Inc.
|
264,056 | $2,664,325 |
All Filings in DMAA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $109,788 | 10,476 | Shares | Defined | 2026-05-15 | |
| 2025-09-30 DMAAU | $124,425 | 11,964 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 DMAAU | $144,748 | 14,026 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 DMAAU | $160,208 | 15,753 | Shares | Defined | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||